GRENOBLE, France–(BUSINESS WIRE)–Ten semiconductor equipment and service providers will be presenting at SEMICON Taiwan – French Pavilion, Hall 1, Booth 1320 from September 8-10. (read the story…) Related items CEA-Leti and Docea Power to Combine Expertise on 3D Integration, Thermal and Low-Power Design Presto Engineering and CEA-Leti to...
Read more »

When natural disasters, like floods in Pakistan or earthquakes in Haiti, strike, Munich Re, the world’s largest reinsurance company, ends up paying part of the bill. Munich Re offers capitalism a safety net, and no other company is more familiar with life’s risks. (read the...
Read more »

EU’s Research Commissioner announced that the European Union would invest 6.4 billion euros in research and innovation. (read the story…) Related items EU innovation chief to leverage structural funds for research (EurActiv) Egypt Builds Reputation as Innovation Powerhouse Nanotechnology partnership Europe invites bids for ?6.4bn in research funding MagForce Nanotechnologies AG...
Read more »

To develop an exaflop computer, a thousand times faster than today’s fastest supercomputers, the government agency is tapping chipmakers Intel and Nvidia, among others. Originally posted at Nanotech – The Circuits Blog (read on…) Related items Stem Cell Industry Leader Dwight Brunoehler Named President of AmStem Corp. Ireland...
Read more »

LAUSANNE, Switzerland, September 2, 2010 /PRNewswire/ — Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, today announced that the ‘Debiopharm Life Sciences Award 2010′ went to Professor...
Read more »

If you have, or like to hear, ideas worth spreading, head for a TED. The acronym is deciphered as Technology, Entertainment, Design, and sums up the basic topics in discussion at any given TED event. (read the story…) Related items Celator Pharmaceuticals raises $20 million in Series...
Read more »

With growing interest in using nanoparticles for everything from antibacterial socks to medical imaging to electronic devices, the need to understand the environmental, health and safety risks of these particles also grows. Researchers at the National Institute of Standards and Technology (NIST) have developed...
Read more »

Celator Pharmaceuticals, a privately held pharmaceutical company developing new and more effective therapies to treat cancer based on the company’s proprietary technology, today announced that it raised $20 million in a Series D private equity financing. (read the story…) Related items Celator® Pharmaceuticals Raises $20 Million in...
Read more »

Researchers clear hurdle on path toward gene-therapy treatment for diseaseOne of the most difficult aspects of working at the nanoscale is actually seeing the object being worked on. Biological structures like viruses, which are smaller than the wavelength of light, are invisible to standard...
Read more »

Celator Pharmaceuticals, a privately held pharmaceutical company developing new and more effective therapies to treat cancer based on the company’s proprietary technology, today announced that it raised $20 million in a Series D private equity financing. Â Proceeds will support completion of ongoing clinical...
Read more »